Form
SCHEDULE 13G
Passive or exempt beneficial ownership filing.
Soleus Capital Master Fund, L.P. - 18 Mar 2025 SCHEDULE 13G Report for PRAXIS PRECISION MEDICINES, INC. Common Stock, $0.0001 par value per share (PRAX)
- Filing manager
- Soleus Capital Master Fund, L.P.
- Reporting owner
- Soleus Capital Master Fund, L.P.
- Beneficially owned shares
- 1,017,740 shares
- Large-stake signal
-
Ownership
5%Beneficial ownership of this reported class.
Shares
1,017,740 sharesShares beneficially owned as disclosed.
Event date
18 Mar 2025Date tied to the ownership event or amendment.
Accepted by SEC
19 Mar 2025EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Class ownership
- 5%
- Symbol
- PRAX
- Shares outstanding
- 20,354,800 shares
- SEC form
- SCHEDULE 13G
- Accepted by SEC
- 19 Mar 2025, 17:00:14 UTC
- Event date
- 18 Mar 2025
- Next SEC filing
- 05 Aug 2025
- Source filing
- View source filing
Ownership signal
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Subject security
Names, identifiers, and filing context for this profile.
2 source fields
Source evidence
Original filing metadata and source links for verification.
5 source fields
Key filing fact
Soleus Capital Master Fund, L.P. disclosed 5% ownership in PRAXIS PRECISION MEDICINES, INC. Common Stock, $0.0001 par value per share (PRAX) on 18 Mar 2025.
Key facts
- Soleus Capital Master Fund, L.P. filed SCHEDULE 13G for PRAXIS PRECISION MEDICINES, INC. Common Stock, $0.0001 par value per share (PRAX).
- Disclosed ownership: 5%.
- Date of event: 18 Mar 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 19 Mar 2025, 17:00.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
View source filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (6)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Soleus Capital Master Fund, L.P. | 5% | 1,017,740 | 0 | 1,017,740 | Soleus Capital, LLC, its General Partner | Guy Levy/Managing Member | |
| Soleus Capital, LLC | 5% | 1,017,740 | 0 | 1,017,740 | Soleus Capital Group, LLC, its Managing Manager, | Guy Levy/Managing Manager | |
| Soleus Capital Group, LLC | 5% | 1,017,740 | 0 | 1,017,740 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Soleus Capital Management, L.P. | 5% | 1,017,740 | 0 | 1,017,740 | Soleus GP, LLC, its General Partner, | Guy Levy/General Partner | |
| Soleus GP, LLC | 5% | 1,017,740 | 0 | 1,017,740 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Guy Levy | 5% | 1,017,740 | 0 | 1,017,740 | /s/ Guy Levy | Guy Levy |
CIK / CUSIP context first